Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nodal Staging in Breast Cancer With MRL

This study has been terminated.
(Manufacturer recently halted production of gadofosveset.)
Sponsor:
Information provided by (Responsible Party):
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT01609920
First received: May 30, 2012
Last updated: November 9, 2016
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2016
  Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)